Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020.

ABSTRACT:

SUBMITTER: Johnston JL 

PROVIDER: S-EPMC8218229 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature